Strides Pharma, Inc.
Summary
- Total Recalls
- 12
- 510(k) Clearances
- 0
- Inspections
- 11
- Compliance Actions
- 0
Known Names
strides pharma, strides pharma science limited
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0546-2025 | Class II | Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd. Pu | July 9, 2025 |
| D-0294-2025 | Class II | Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pha | March 5, 2025 |
| D-0293-2025 | Class II | Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides | March 5, 2025 |
| D-0260-2024 | Class II | Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Lt | December 29, 2023 |
| D-0895-2023 | Class II | Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured b | June 26, 2023 |
| D-1330-2022 | Class II | Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Lt | July 19, 2022 |
| D-0974-2022 | Class II | Losartan Potassium Tablets, USP, 100 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Lim | May 18, 2022 |
| D-0973-2022 | Class II | Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limi | May 18, 2022 |
| D-0972-2022 | Class II | Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life Sciences Private Limi | May 18, 2022 |
| D-0006-2022 | Class II | Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured | September 27, 2021 |
| D-0180-2021 | Class III | NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma S | December 22, 2020 |
| D-0858-2017 | Class III | Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Ban | May 9, 2017 |